Paris - Topical imiquimod offers safe and often effective treatment for basal cell carcinomas (BCCs) in immunosuppressed, solid organ transplantation patients, David Vidal, M.D., said at the World Congress of Dermatology.
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Indoor Tanning and Melanoma
Skin Barrier 101: Keep Up with What Your Patients Are Reading
2 Clarke Drive Cranbury, NJ 08512